Sector: Pharmaceuticals & Biotechnology

Small Cap

Jagsonpal Pharma Share Price

JAGSNPHARM

₹226.55

-3.51(-1.53%)

14th Jul 2026 | 12:18 PM

NSE : JAGSNPHARM

Open Free Demat Account

Jagsonpal Pharma Performance

Price Movement

₹226.55

₹224.92

₹229.91

↘ Today's Low↗ Today's High

1 Year Performance

₹226.55

₹155.00

₹301.65

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹229.91

Low₹224.92

Open at₹229.00

Prev Close₹230.06

Volumes24.77 K

Avg Price₹227.03

Lower Circuit₹184.05

Upper Circuit₹276.07

Historical Performance

3M High₹264.50

3M Low₹184.50

1 Yr High₹301.65

1 Yr Low₹155.00

3 Yr High₹328.04

3 Yr Low₹109.44

5 Yr High₹328.04

5 Yr Low₹49.20

Summary

As of 14-07-2026 12:53, Jagsonpal Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-230.06 (-100.00%) from the previous close of ₹230.06. The stock opened at ₹229 and traded between ₹224.92 and ₹229.91, with a total traded volume of 24768 shares. The company has a market capitalization of ₹1532.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹301.65 and ₹155, respectively.

Jagsonpal Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 35.6, and book value of ₹5.60. Profitability indicators show ROE of 15.59% along with a dividend yield of 1.1%. Jagsonpal Pharmaceuticals Ltd. has reported revenue of ₹287.22 Cr and net profit of ₹43.08 Cr.

Jagsonpal Pharmaceuticals Ltd. technical indicators include Day RSI at 60.02, Day MFI at 88.09, Day ADX at 34.53. Additional indicators include Commodity Channel Index (CCI) at 49.5 and Williams %R at -60.76. Momentum indicators show Day MACD at 6.96, Day MACD Signal Line at 7.23, DayATR at 11.13. Rate of Change indicators for Jagsonpal Pharmaceuticals Ltd. include ROC125 at 22.41 and ROC21 at 13.81.

Exponential moving averages include EMA5 at ₹233.1, EMA10 at ₹232, EMA12 at ₹231, EMA20 at ₹226.8, EMA26 at ₹224, EMA50 at ₹215.6, EMA100 at ₹207.4, EMA200 at ₹205.9. Simple moving averages include SMA5 at ₹233.8, SMA10 at ₹234.7, SMA20 at ₹226, SMA30 at ₹218.5, SMA50 at ₹214.4, SMA100 at ₹198.9, SMA150 at ₹195.2, SMA200 at ₹201.

Support levels for Jagsonpal Pharma are placed at First Support ₹229.21, Second Support ₹225.66, Third Support ₹220.31. Resistance levels are seen at First Resistance ₹238.11, Second Resistance ₹243.46, Third Resistance ₹247.01. Jagsonpal Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 67.89%, FII holding at 2.44%, DII holding at 0%, public holding at 29.44%.

Jagsonpal Pharma Fundamentals

Market Cap

Above industry Median

1,532.50 Cr.

PE Ratio (TTM)

Above industry Median

35.60

Dividend Yield

Above industry Median

1.10

Net Profit TTM

22% decr over last year

43.08

Net Profit Growth

22% decr over last year

43.08

PEG Ratio

Negative PEG TTM

-1.60

ROE

33% decr over last year

15.59

Operating Revenue TTM

287.22

Operating Revenue Growth

6.9% incr over last year

Book Value

Above industry Median

5.60

MFI

MFI strongly Overbought

88.09

RSI

RSI is mid-range

60.02

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

5.60

Jagsonpal Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	64.20	72.94	74.46	75.61	58.56
Operating Expense	53.04	56.68	58.03	61.40	49.85
Operating Profit	11.16	16.27	16.43	14.21	8.71
Depreciation	2.32	2.39	2.39	2.35	2.30
Interest	0.25	0.26	0.26	0.25	0.26
Tax	2.99	3.57	4.24	3.64	2.12
Net Profit	8.76	10.95	12.57	10.80	6.58

Jagsonpal Pharma Technicals

Jagsonpal Pharmaceuticals Ltd. EMA & SMA

₹226.55

-5.34 (-2.30%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹233.1

Day EMA10 ₹232

Day EMA12 ₹231

Day EMA20 ₹226.8

Day EMA26 ₹224

Day EMA50 ₹215.6

Day EMA100 ₹207.4

Day EMA200 ₹205.9

Jagsonpal Pharma Support and Resistance

Resistance

First Resistance₹238.11

Second Resistance₹243.46

Third Resistance₹247.01

Support

First Support₹229.21

Second Support₹225.66

Third Support₹220.31

Technical Indicators

Day RSI60.02

Day MFI88.09

Day ADX34.53

Day Commodity Channel Index49.50

William-60.76

Day MACD6.96

Day MACD Signal Line7.23

Day ATR11.13

Day ROC12522.41

Day ROC2113.81

Jagsonpal Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	67.8	67.8	67.6	67.5	67.4	67.9
FII	2.1	2.1	2.2	2.1	2.1	2.4
DII	0	0	0	0.1	0.2	0.3
Public	30.1	30.1	30.1	30.2	30.3	29.4

Jagsonpal Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	25.29 K	60.45 K	41.83%
Week	54.93 K	1.54 L	35.59%
1 Month	1 L	6.98 L	14.34%
6 Month	82.71 K	2.62 L	31.55%

Jagsonpal Pharma SWOT Analysis

Strengths18

Weakness7

Opportunity1

Threats0

Companies with no Debt

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Jagsonpal Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
12 Sep, 2025	2.5	FINAL	12 Sep, 2025	Equity Share
06 Sep, 2024	5	FINAL	06 Sep, 2024	Equity Share
21 Aug, 2023	5	FINAL	21 Aug, 2023	Equity Share
29 Oct, 2021	4	INTERIM	01 Nov, 2021	Equity Share
22 Sep, 2021	1	FINAL		Equity Share
22 Sep, 2020	0.5	FINAL		Equity Share
20 Sep, 2019	0.25	FINAL		Equity Share
18 Sep, 2018	0.1	FINAL		Equity Share
21 Sep, 2017	0.1	FINAL		Equity Share
21 Sep, 2016	0.1	FINAL		Equity Share

Jagsonpal Pharma Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹136.50	₹578.95	₹5.27	₹98	₹172.08	₹15.10
% Change	-2.15%	-1.23%	-1.68%	-2.92%	-2.00%	-1.88%
Revenue TTM (₹ Cr)	-	-	₹83.60	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-34.95	-	₹14.88	₹27.81
PE TTM	62.10	-	-1.30	11.80	46.80	29.80
1 Year Return	-6.47	50.03	441	-21.33	42.2	71.32
ROCE	-	3.56	-5.63	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.00

+2.70%

INFLUX

Influx Healthtech Ltd.

₹ 298.00

-2.30%

MEDIORG

Medicamen Organics Ltd.

₹ 23.50

+0.64%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 536.80

-0.68%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 64.00

+0.39%

SIGACHI

Sigachi Industries Ltd.

₹ 23.58

+1.99%

WINDLAS

Windlas Biotech Ltd.

₹ 852.45

+0.02%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.94

+0.44%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 573.15

-2.09%

ZIMLAB

Zim Laboratories Ltd.

₹ 118.20

+1.99%

MEDICO

Medico Remedies Ltd.

₹ 38.80

-0.94%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 192.93

-2.03%

LASA

Lasa Supergenerics Ltd.

₹ 7.34

+0.27%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 325.50

-1.80%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 338.60

-1.33%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.00

+0.00%

BROOKS

Brooks Laboratories Ltd.

₹ 70.68

+1.19%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2757.50

-2.32%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 212.87

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 73.30

+6.37%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 405.00

+1.30%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.22

+1.17%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.72

-0.89%

INDOCO

Indoco Remedies Ltd.

₹ 256.00

-1.17%

FAQ's on JAGSNPHARM

What is the current share price of Jagsonpal Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Jagsonpal Pharmaceuticals Ltd. is ₹ 226.55 on the NSE and ₹ 226 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Jagsonpal Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Jagsonpal Pharmaceuticals Ltd. is approximately ₹ 1532.5 Cr.

What are the PE and PB ratios for Jagsonpal Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Jagsonpal Pharmaceuticals Ltd. is 35.6, and the Price-to-Book (PB) ratio is 5.6.

What is the 52-Week High and Low for Jagsonpal Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Jagsonpal Pharmaceuticals Ltd. shares was ₹ 301.65, and the lowest price was ₹ 155.

What is the current dividend yield for Jagsonpal Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for Jagsonpal Pharmaceuticals Ltd. is 1.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Jagsonpal Pharmaceuticals Ltd.?

Significant shareholdings in Jagsonpal Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Jagsonpal Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Jagsonpal Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Jagsonpal Pharmaceuticals Ltd.?

Jagsonpal Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 2.5 per share for the financial period ending 2025. The record date was set as 2025-09-12, and the payment was/is scheduled around 2025-09-12. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy